Healthcare >> Analyst Interviews >> October 26, 2004

SMALL TO MID-CAP BIOTECHNOLOGY COMPANIES: NAVDEEP JAIKARIA – RODMAN & RENSHAW INC

NAVDEEP S. JAIKARIA joined Rodman & Renshaw, Inc., as a Senior Biotechnology Analyst in July 2003. Previously, Dr. Jaikaria was a Senior Biotechnology Analyst covering small and mid-cap biotechnology companies at Leerink Swann & Company as well as Mehta Partners. Dr. Jaikaria obtained his PhD at New York Medical College in Cell Biology and Anatomy and conducted postdoctoral research at The Rockefeller University. His scientific research focused on infectious diseases and cancer. Before joining Wall Street, Dr. Jaikaria also served as a consultant to biotechnology and pharmaceutical companies. Profile
TWST: Navdeep, would you please give us a quick overview of what you're

covering in the biotech space?

Mr. Jaikaria: My coverage focuses on small to mid-cap biotechnology

names. I have